Providing ultimate value to stakeholders remains key in new style of development.
Ferry Tamtoro
Advertisement
Co-founder and CTO, BrightInsight
Articles by Ferry Tamtoro
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
3
Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial
4
Novo Nordisk Stock Reacts to Recent Board Changes
5
